BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 11176533)

  • 1. Chronic ischemia alters prostate structure and reactivity in rabbits.
    Kozlowski R; Kershen RT; Siroky MB; Krane RJ; Azadzoi KM
    J Urol; 2001 Mar; 165(3):1019-26. PubMed ID: 11176533
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Overactivity and structural changes in the chronically ischemic bladder.
    Azadzoi KM; Tarcan T; Kozlowski R; Krane RJ; Siroky MB
    J Urol; 1999 Nov; 162(5):1768-78. PubMed ID: 10524933
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Atherosclerosis-induced chronic ischemia causes bladder fibrosis and non-compliance in the rabbit.
    Azadzoi KM; Tarcan T; Siroky MB; Krane RJ
    J Urol; 1999 May; 161(5):1626-35. PubMed ID: 10210430
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Relative roles of cyclooxygenase and nitric oxide synthase pathways in ischemia-induced increased contraction of cavernosal smooth muscle.
    Azadzoi KM; Krane RJ; Saenz de Tejada I; Goldstein I; Siroky MB
    J Urol; 1999 Apr; 161(4):1324-8. PubMed ID: 10081902
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Increased leukotriene and prostaglandin release, and overactivity in the chronically ischemic bladder.
    Azadzoi KM; Shinde VM; Tarcan T; Kozlowski R; Siroky MB
    J Urol; 2003 May; 169(5):1885-91. PubMed ID: 12686867
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Alteration of urothelial-mediated tone in the ischemic bladder: role of eicosanoids.
    Azadzoi KM; Heim VK; Tarcan T; Siroky MB
    Neurourol Urodyn; 2004; 23(3):258-64. PubMed ID: 15098224
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Chronic ischemia increases prostatic smooth muscle contraction in the rabbit.
    Azadzoi KM; Babayan RK; Kozlowski R; Siroky MB
    J Urol; 2003 Aug; 170(2 Pt 1):659-63. PubMed ID: 12853851
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mechanisms of ischemia-induced cavernosal smooth muscle relaxation impairment in a rabbit model of vasculogenic erectile dysfunction.
    Azadzoi KM; Goldstein I; Siroky MB; Traish AM; Krane RJ; Saenz de Tejada I
    J Urol; 1998 Dec; 160(6 Pt 1):2216-22. PubMed ID: 9817373
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The effect of atherosclerosis-induced chronic bladder ischemia on bladder function in the rat.
    Nomiya M; Yamaguchi O; Andersson KE; Sagawa K; Aikawa K; Shishido K; Yanagida T; Kushida N; Yazaki J; Takahashi N
    Neurourol Urodyn; 2012 Jan; 31(1):195-200. PubMed ID: 21905085
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of oral Tadenan treatment on rabbit bladder structure and function after partial outlet obstruction.
    Levin RM; Hass MA; Bellamy F; Horan P; Whitbeck K; Chow PH; Kung LS; Gosling J
    J Urol; 2002 May; 167(5):2253-9. PubMed ID: 11956488
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Intracavernosal injections of vascular endothelial growth factor protects endothelial dependent corpora cavernosal smooth muscle relaxation in the hypercholesterolemic rabbit: a preliminary study.
    Henry GD; Byrne R; Hunyh TT; Abraham V; Annex BH; Hagen PO; Donatucci CF
    Int J Impot Res; 2000 Dec; 12(6):334-9. PubMed ID: 11416837
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Changes in the threshold voltage and alterations of smooth-muscle physiology after bladder outlet obstruction.
    Eroğlu E; Kücukhuseyin C; Ayik B; Dervisoglu S; Emir H; Danişmend N
    Eur J Pediatr Surg; 2004 Feb; 14(1):39-44. PubMed ID: 15024678
    [TBL] [Abstract][Full Text] [Related]  

  • 13. NTP Toxicology and Carcinogenesis Studies of 1-Amino-2,4-Dibromoanthraquinone (CAS No. 81-49-2) in F344/N Rats and B6C3F1 Mice (Feed Studies).
    National Toxicology Program
    Natl Toxicol Program Tech Rep Ser; 1996 Aug; 383():1-370. PubMed ID: 12692653
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Normalization of coronary microvascular reactivity and improvement in myocardial perfusion by surgical vascular endothelial growth factor therapy combined with oral supplementation of l-arginine in a porcine model of endothelial dysfunction.
    Voisine P; Bianchi C; Khan TA; Ruel M; Xu SH; Feng J; Li J; Malik T; Rosinberg A; Sellke FW
    J Thorac Cardiovasc Surg; 2005 Jun; 129(6):1414-20. PubMed ID: 15942586
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of L-arginine on the endogenous angiogenic response in a model of hypercholesterolemia.
    Nakai Y; Voisine P; Bianchi C; Xu SH; Feng J; Malik T; Rosinberg A; Sellke FW
    Surgery; 2005 Aug; 138(2):291-8. PubMed ID: 16153439
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Decreases in corporeal vascular endothelial growth factor expression precede vasoreactivity changes in cholesterol fed rabbits.
    Xie D; Thompson MA; Pippen AM; Waters RE; Donatucci CF; Annex BH
    J Urol; 2005 Apr; 173(4):1418-22. PubMed ID: 15758816
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The effect of chronic partial bladder outlet obstruction on corpus cavernosum smooth muscle and Rho-kinase in rabbits.
    Lin WY; Mannikarottu A; Chichester P; Neuman P; Johnson A; Pérez-Martínez FC; Levin RM
    Neurourol Urodyn; 2008; 27(8):826-31. PubMed ID: 18551564
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prophylactic role of oral L-arginine on histological and contractile changes in a rat chronic bladder injury model.
    Ozgür A; Onol FF; Ercan F; Tarcan T
    Urol Int; 2008; 81(3):347-52. PubMed ID: 18931556
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Modifiable risk factors for benign prostatic hyperplasia and lower urinary tract symptoms: new approaches to old problems.
    Parsons JK
    J Urol; 2007 Aug; 178(2):395-401. PubMed ID: 17561143
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Enhanced force generation by corpus cavernosum smooth muscle in rabbits with partial bladder outlet obstruction.
    Chang S; Hypolite JA; Zderic SA; Wein AJ; Chacko S; DiSanto ME
    J Urol; 2002 Jun; 167(6):2636-44. PubMed ID: 11992100
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.